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Early diagnosis and treatment of congenital hypothyroidism (CH) and the 
prevention of developmental retardation is the main goal of public health national 
screening programs. This study compares the cognitive ability of children with 
CH diagnosed by neonatal screening with a healthy control group (2007) in 
Yazd, Iran. 
Materials & Methods
 In a case-controlled study, the intelligent quotient (IQ) of 40 five-year-old 
children with early treated CH and good compliance were evaluated by the 
Wechsler preschool and primary scale of intelligent test and compared to 40 
healthy age and gender matched children as controls.
Results
22 boys (55%) and 18 girls (45%) in both groups were evaluated. In children 
with CH, 19 (47.5%) and 21 (52.5%) persons had transient and permanent 
hypothyroidism, respectively.
Range of TSH and T4 level at the onset of diagnosis were 11.41–81 mu/l and 
1.50–14.20 µg/dl, respectively.
The intelligence levels of all children with CH were within the average or normal 
range and IQs ranged from 91–108.
Children with CH had lower full-scale IQs (107.25 ± 2. 9 versus 110.50 ± 2.66, 
p=0.001), verbal IQ (106.95 ± 3.5 versus 109.90 ± 3.44, P-value=0.001) and 
performance IQ (106.3 ± 3.68 versus 108.87 ± 3.70) than the control group. 
However, no statistically significant differences were observed for mean IQ 
scores in permanent and transient CH.
Conclusion
Children with CH who had early treatment and good compliance had normal 
cognitive abilities, but may have a decreased IQ relative to the healthy control 
group. 
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ORIGINAL  ARTICLE
Introduction
Congenital hypothyroidism (CH) is the most common congenital endocrine 
disorder for children and it is one of the most important preventable causes of 
developmental retardation. The majority of neonates with CH is asymptomatic at 
birth and can be identified through neonatal screening programs. The incidence of 
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congenital hypothyroidism based on screening tests has 
been estimated to be 1/3000 worldwide. Levothyroxine 
treatment with proper dosage should be started in the 
first weeks of life and continued at least up to 3 years 
of age. (1)
The nationwide neonatal CH screening programs were 
started in Iran by the Ministry of Health State Welfare 
Organization in 2005. The screening program used the 
measurement of TSH in filtered paper blood spots within 
3–5 days after birth. The prevalence of CH in Iran is 
significantly higher than its prevalence worldwide (2-6). 
Neurodevelopmental outcomes of CH children have 
been evaluated in different countries by different 
developmental assessment tests, which have debatable 
results. Mild impairments in cognitive and language 
abilities, poorer motor skills, speech and learning 
problems, lower intelligent quotient (IQ), incoordination, 
hypotonia or hypertonia, and short attention spans may 
occur in neonates with CH even with a timely diagnosis 
and proper treatment (1, 7, 8).
 In some studies, no significant difference was seen 
in the IQs of children with CH and in normal healthy 
children (9, 10). However, in a study in Rotterdam, The 
Netherlands, over treated CH patients who were 5–7 
years of age had higher global IQ scores than the control 
children did (10).
Minor and mild developmental disabilities in 
children with CH may not be detected in infancy, in 
early childhood, and are recognized by those with 
developmental delays before school entry, instead of 
waiting for more harsh problems that may arise later 
on, could aid to halt unnecessary problems in them 
and for their parents, and assessment of these children 
in preschool age might be more useful. A few studies 
compared developmental outcome of children with CH 
to matched controls.
This study evaluates and compares developmental 
outcomes and cognitive abilities of children with 
congenital hypothyroidism diagnosed by neonatal 
screening with a healthy control group of children in 
Yazd, Iran.
Materials & Methods
In a case-control study, the cognitive functions for all 
singleton, term (gestational age = 37–42 weeks) neonates 
with congenital hypothyroidism that was diagnosed by 
neonatal screening in the city of Yazd, Iran in 2007 and 
for whom levothyroxine treatment in an adequate dosage 
was started in a timely manner (at less than one month of 
age), had good compliance, and had regular follow ups 
were assessed at the age of 5.
The control group consisted of 40 singleton, term, 
five-year-old healthy gender and socioeconomic 
status matched control children who were referred for 
vaccination to the primary health care center of Niko 
poor in 2012. 
Multiple pregnancies, severe neonatal jaundice, and 
exchange transfusion, preterm neonates, severe asphyxia, 
NICU admission, children with major congenital 
malformations, chromosomal abnormalities, and genetic 
syndromes were excluded.
Phone numbers, TSH, and T4 level at diagnosis, age at 
the onset of treatment, and type of CH (permanent or 
transient) for all children with CH who were diagnosed 
by neonatal screening in 2007 were found via records of 
the City Health Center of Yazd. 
Then, we called them and the importance of cognitive 
assessment and early detection of developmental 
delays was explained to the parents of CH patients. The 
parents were asked to take part in the study and bring 
their children into the Pediatric Endocrinology Clinic of 
Shahid Sadoughi University of Medical Sciences (Yazd, 
Iran) for cognitive assessment by a trained pediatric 
resident. 
All children with CH were euthyroid at the time of 
intellectual and cognitive testing.
Cognitive ability of children was assessed by the Persian 
version of the Wechsler Preschool and Primary Scale 
of Intelligent (WPPSI). Patient performance on the 11 
subtests and three IQ scores were derived as follows: 
verbal IQ (VIQ), performance IQ (PIQ), and full-scale 
IQ (FSIQ) measuring general intellectual ability. In the 
normative population, each IQ score has a mean of 100 
and a standard deviation of 15. The subtest scaled scores 
have a mean of 10 and a standard deviation of 3. For 
Quotient and Composite scores as follows: below 70 
is Extremely Low; 70–79 is borderline, 80–89 is Low 
Average, 90–109 is Average, 110–119 is High Average, 
and 120–129 is Superior (11).
The data were analyzed with SPSS (ver 17). A Chi-
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square test or Fisher exact test was used for data analysis 
of qualitative variables. Mean values were compared 
for the two groups by an independent t-test and in three 
groups by the ANOVA test.
Differences  were considered significant when P-values 
were less than 0.05.
The study was approved by the Ethics Committee of 




The parents of five children with CH refused to take part 
in the research. Finally, 40 five-year-old children with 
CH including 22 boys (55%) and 18 girls (45%) were 
evaluated and compared with 40 healthy age, gender, 
socioeconomic status, and race matched control children.
In children with CH, 19 (47.5%) and 21 (52.5%) 
persons had transient and permanent hypothyroidism, 
respectively.
TSH levels at diagnosis were in the range of 11.41–81 
mu/l with mean level of 19.53 ± 17.80 mu/l.
T4 levels at the onset of treatment were in the range of 
1.50–14.20 µg/dl with mean level of 6.50 ± 2.59 µg/dl.
The intelligence levels of all children with CH were 
within the average or normal range and ranged from 
91–108.
Table 1 presents a comparison of mean IQ scores in 
all cognitive domains for both groups and is indicative 
of  statistically significant lower mean verbal IQ, 
performance IQ, and full-scale IQ scores in CH children. 
However, no statistically significant differences were 
seen for the mean of all IQ scores in permanent and 
transient CH.
Table 1 shows a comparison of mean IQ scores in all 
cognitive domains in children with CH based on T4 
level and age at the onset of treatment; and indicates no 
observed statistically significant differences for these 
variables.
Six children had a TSH level greater than 6 mu/l during at 
follow up and the mean full-scale IQ was lower in these 
children (101.02 ± 3. 1 versus 112.78 ± 1.98; p=0.01).
 
Discussion
In the present study, WPPSI was used for the evaluation 
of cognitive abilities of all neonates with CH detected 
by neonatal screening and the results show that these 
children had normal IQ scores, which agrees to other 
studies (9, 10, 12-17).
In this study, children with CH had a mean of verbal IQ, 
performance IQ, and full-scale IQ scores that were lower 
than for healthy socioeconomic status matched controls.
In a study conducted in Zurich, Switzerland, children with 
CH showed lower full-scale IQ up to adolescents in spite 
of early treatment in high-doses and optimal substitution 
therapy in childhood (18). In other studies, CH children 
with early treatment had lower neurological scores 
(7); lower mean global IQ, verbal, and performance 
scores (19, 20, 21); had poorer academic performance 
in the early years (19); and intellectual deficits during 
childhood and adulthood (22).
In another Iranian study, the mean of global IQ of 18 
children with transient CH at year 9 with the Raven and 
Bender-Gestalt tests was lower than the 19 matched 
control children but psychomotor performance was not 
significantly different in both groups (23).
In a study in Naples, Italy, 13 of 40 children with CH 
at 12-years of age showed subnormal IQ scores when 
compared with their siblings but the mean  full IQ score 
was not significantly different in both groups (24).
In the present study, T4 levels in the screening test had 
no effect on developmental outcomes for children with 
CH; this result complies with other studies (12, 13, 
17, 22). Nevertheless, in some studies, neonates with 
severe hypothyroidism and very low serum T4 level 
(less than 2µg/dl) had lower cognitive scores and worse 
neurodevelopmental outcomes (7,19 ,20,21,24,25).
In this study, the length of levothyroxine therapy had 
no effect on the cognitive abilities of children with CH, 
this agrees with other studies (12, 13, 20, 21, 22, 25). 
However, in a study in Paris, France, the IQ of infants 
who were treated after 21 days was lower than the 
control group (16). 
Some persistent developmental deficits are likely related 
to genetic influences that exist regardless of therapy 
effectiveness (15).
Possible explanations for these discrepancies are as 
follows: age, race, geographic area, sample size, control 
group, and the genetics of children. 
In conclusion, based on our results, children 
with CH with early treatment (in the first month) 
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and good compliance had normal cognitive and 
neurodevelopmental outcomes, but may have decreased 
IQ relative to a healthy control group.
Early intellectual assessment of children with CH, 
the promotion of parental pedagogic attitude, and 
the encouragement of parents for the continuation of 
treatment and regular follow-ups should be done.
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Mean ± SD Healthy control
Mean ± SD
P-value
Permanent CH Transient CH P-value Total CH
Verbal-IQ 106.85 ± 3.03 107.05 ± 4.04 0.86 106.95 ± 3.5 109.90 ± 3.44 0.001
Performance-IQ 106.66 ± 3.66 105.89 ± 3.76 0.51 106.3 ± 3.68 108.87 ± 3.70 0.001
Full-IQ 107.33 ± 2.79 107.50 ± 3.07 0.85 107.25 ± 2.9 110.50 ± 2.66 0.001
Table 2. Comparison of Mean of IQ Scores in All Cognitive Domains in Children with Congenital Hypothyroidism 
Based on T4 Level and Age at the Onset of the Treatment
Full-IQPerformance-IQVerbal-IQIQ






105.85 ± 3.38< 4 µg/dl
T4 level at diag-
nose onset 
106.82± 2.48106.23± 3.40106.11 ± 3.374-7 µg/dl






101.1± 3.12<7 dayAge at the onset of 
the treatment 106.95± 2.99105.86± 3.57107.04± 3.657-21 day
107.82± 2.74106.94± 3.94107.17± 3.1822-30 day
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